Lung Cancer

Travel Insurance for Lung Cancer Patients

Lung cancer is one of the more challenging cancers to navigate for travel insurance purposes locally. That said, it is not impossible — particularly for people with early-stage disease that has been surgically removed, or those in confirmed long-term remission.

The Fit-to-Fly Question

Before travel insurance even becomes the primary concern, lung cancer patients must address whether they are medically fit to fly. Aircraft cabins are pressurised to an equivalent altitude of roughly 6,000–8,000 feet above sea level. This means the oxygen partial pressure in cabin air is lower than at sea level — which can be significant for people with reduced lung capacity.

Your respiratory physician or oncologist can arrange a Hypoxia Altitude Simulation Test (HAST) — sometimes called a Fit-to-Fly test — which assesses whether your blood oxygen levels remain safe at simulated cabin pressure. If your resting oxygen saturation is already below 95%, in-flight supplemental oxygen may be required.

In-Flight Oxygen

If supplemental oxygen is required, this must be arranged with the airline well in advance — typically 6–8 weeks before departure. Not all airlines provide supplemental oxygen; those that do charge an additional fee and require a medical form from your doctor. You cannot bring your own oxygen cylinder onboard. Some airlines have minimum oxygen saturation thresholds below which they will not carry passengers.

Insurance Assessment for Lung Cancer

Most travel insurers will assess lung cancer cases individually. Key factors affecting the assessment:

• Stage at diagnosis: Stage 1 resected (surgically removed) non-small cell lung cancer in long-term remission is generally more assessable than advanced-stage disease.
• Histology: Non-small cell lung cancer (NSCLC) versus small cell lung cancer (SCLC) — SCLC is generally more aggressive and harder to cover.
• Current treatment: Active chemotherapy or immunotherapy makes assessment more complex.
• Metastatic disease: Lung cancer with brain, bone, or other metastases significantly reduces the likelihood of cover.
• Respiratory function: Current lung function tests (FEV1, DLCO) may be requested.

Targeted Therapies and Immunotherapy

Many lung cancer patients are now managed with targeted therapies (EGFR, ALK, ROS1 inhibitors) or immunotherapy (pembrolizumab, nivolumab). These are generally manageable for travel purposes, but:

• Carry all medications in your carry-on in original packaging
• Carry a physician's letter explaining your treatment
• Be aware that immunotherapy-related pneumonitis (lung inflammation) is a rare but serious complication that could be triggered or worsened by altitude or respiratory stress

Destination Advice

Sea-level or low-altitude destinations are significantly preferable. Avoid high-altitude cities (La Paz, Cusco, Quito, Lhasa), mountain regions (Alps, Andes, Himalayas), and high-altitude safari lodges. Australia, Pacific Islands, Southeast Asian coastal areas, and the UK are all at or near sea level.

Realistic Expectations

For early-stage resected lung cancer in confirmed remission (2+ years post-surgery), obtaining travel insurance with an additional premium is realistic. For active advanced-stage lung cancer, cover for the cancer itself may not be available — but a policy that covers other travel risks (cancellation, baggage, other medical events) may still be possible.

Always get a fit-to-fly clearance first. Without it, your travel insurance claim could be challenged on the basis that the airline should not have carried you.